MARIA YOLANDA DIEBOLD LUQUE-rekin lankidetzan egindako argitalpenak (30)

2020

  1. Erratum: Correction to: Optimization of Human Limbal Stem Cell Culture by Replating a Single Limbal Explant (Methods in molecular biology (Clifton, N.J.) (2020) 2145 (39-49))

    Methods in molecular biology (Clifton, N.J.)

  2. Optimization of human limbal stem cell culture by replating a single limbal explant

    Methods in Molecular Biology (Humana Press Inc.), pp. 39-49

2015

  1. Variation in the expression of inflammatory markers and neuroreceptors in human conjunctival epithelial cells

    Ocular Surface, Vol. 3, Núm. 4, pp. S145-S148

2014

  1. CD44 and RHAMM hyaluronan receptors in human ocular surface inflammation

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 252, Núm. 8, pp. 1289-1295

2013

  1. A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model

    Gene Therapy, Vol. 20, Núm. 5, pp. 467-477

2011

  1. Intracellular trafficking of hyaluronic acid-chitosan oligomerbased nanoparticles in cultured human ocular surface cells

    Molecular Vision, Vol. 17, pp. 279-290

2010

  1. Applications of nanoparticles in ophthalmology

    Progress in Retinal and Eye Research, Vol. 29, Núm. 6, pp. 596-609

  2. Dry eye disease as an inflammatory disorder

    Ocular Immunology and Inflammation, Vol. 18, Núm. 4, pp. 244-253

  3. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles

    Cornea, Vol. 29, Núm. 5, pp. 550-558

2009

  1. Characterization and short-term culture of cells recovered from human conjunctival epithelium by minimally invasive means.

    Molecular vision, Vol. 15, pp. 2185-2195

  2. Comparison of gene expression profiles of conjunctival cell lines with primary cultured conjunctival epithelial cells and human conjunctival tissue

    Gene Expression, Vol. 14, Núm. 5, pp. 265-278

  3. Genetically engineered elastin-like polymer as a substratum to culture cells from the ocular surface

    Current Eye Research, Vol. 34, Núm. 1, pp. 48-56

2008

  1. Chitosan-Based Colloidal Systems as Promising Topical Drug Carriers for Ocular Surface Disorders

    PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS

  2. Cytokine responses by conjunctival epithelial cells: An in vitro model of ocular inflammation

    Cytokine, Vol. 44, Núm. 1, pp. 160-167

2007

  1. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)

    Biomaterials, Vol. 28, Núm. 8, pp. 1553-1564

2006

  1. Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis

    Archives of Ophthalmology, Vol. 124, Núm. 4, pp. 462-468

  2. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance

    Investigative Ophthalmology and Visual Science, Vol. 47, Núm. 4, pp. 1416-1425

2005

  1. Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium

    Investigative Ophthalmology and Visual Science, Vol. 46, Núm. 2, pp. 504-513

  2. α2-adrenergic receptors are present in normal human conjunctiva

    Current Eye Research, Vol. 30, Núm. 12, pp. 1121-1129

2004

  1. Impression cytology of the ocular surface: A review

    Experimental Eye Research, Vol. 78, Núm. 3, pp. 457-472